Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01419002
What this trial is testing

Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer

Who this might be right for
Pancreatic Adenocarcinoma
CHIR-Net 5
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableStudy completedNCT03616431
What this trial is testing

Pancreatic Cancer Dietary Assessment Study

Who this might be right for
Pancreatic NeoplasmPancreas AdenocarcinomaWell-Differentiated Neuroendocrine Carcinoma+1 more
The Christie NHS Foundation Trust 112
Early research (Phase 1)Study completedNCT00638612
What this trial is testing

AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer
Candel Therapeutics, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT00005053
What this trial is testing

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 35
Testing effectiveness (Phase 2)Study completedNCT02428270
What this trial is testing

GSK2256098 and Trametinib in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Not applicableNot Yet RecruitingNCT07709052
What this trial is testing

Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Intraductal Papillary Mucinous Neoplasm of PancreasPancreatic Intraepithelial Neoplasia
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 180
Testing effectiveness (Phase 2)Ended earlyNCT02207985
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Karolinska Institutet 10
Not applicableEnded earlyNCT05124743
What this trial is testing

HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

Who this might be right for
Ovarian CancerEndometrial CancerColo-rectal Cancer+3 more
Alaunos Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT02440958
What this trial is testing

Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Yonsei University 50
Testing effectiveness (Phase 2)Temporarily pausedNCT00637364
What this trial is testing

High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain

Who this might be right for
PainPancreatic AdenocarcinomaDuctal Adenocarcinoma
CMED HIFU Development Corporation 5
Early research (Phase 1)Study completedNCT02501902
What this trial is testing

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 76
Not applicableUnknownNCT04814251
What this trial is testing

Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study

Who this might be right for
Pancreatic Adenocarcinoma
Poitiers University Hospital 200
Not applicableLooking for participantsNCT07342231
What this trial is testing

FAPi PET in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma Pancreas
Tata Memorial Hospital 60
Large-scale testing (Phase 3)Study completedNCT00032175
What this trial is testing

Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Research UK 508
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827053
What this trial is testing

Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 36
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Not applicableUnknownNCT05448157
What this trial is testing

68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET

Who this might be right for
Neuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net
European Institute of Oncology 20
Next Page